Lv5
1060 积分 2023-02-02 加入
Crystal structure of the nucleosome core particle at 2.8 Å resolution
4天前
已完结
Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin
4天前
已完结
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells
13天前
已完结
Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody–Drug Conjugates
25天前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
2个月前
已完结
Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer
3个月前
已完结
Strategies for the discovery of oral PROTAC degraders aimed at cancer therapy
3个月前
已完结
Protein degraders enter the clinic — a new approach to cancer therapy
3个月前
已完结
Exploring the next generation of antibody–drug conjugates
3个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
3个月前
已完结
皖公网安备34019202002308
